impact innovation
Making the hope of early detection, a reality.
breakthrough products designed for massive scale across B2B & B2C markets.
iBreastExam (B2B)
Award-winning, patent-pending, radiation-free, ultra-portable wireless device, usable by lay health-workers to identify and document small, non-palpable lumps, quickly and easily, at the point-of-care.
FDA cleared. In commercialization.
cervAIcal (B2B)
AI enabled mobile colposcope
for cervical cancer screening. CervAIcal is a high-quality, wireless universal cervical examination assistant that goes where the patients are. Ongoing Pilots.
Selfi (B2C)
World's first, at home
breast health monitoring
device / app / platform
built with iBreastExam technology
Commercial launch expected in 2022
Our Distribution Partners
Global Leaders. Market Shapers. Impact Makers.
Gov. of India company and the largest health PSU
World leading player in imaging and diagnostics
Malaysia's leading pharma company
A leading preventive health company based in Colombia
A leading preventive health company in South Africa
Facts & Figures
Some statistics from our journey thus far. Read more...
2 Million+
breast exams enabled
500+
Cancers Detected
10
Markets Entered
$1.7M+
Grant Awards
$8.5M
Capital Raised
15+
Awards
Contact Us
You + Us = Awesome
UE LifeSciences Inc. Copyright © 2021 | Terms & Conditions